TACC3 promotes prostate cancer cell proliferation and restrains primary cilium formation

Area of Science:

• Oncology
• Cell Biology
• Molecular Mechanisms

Background:

• Primary cilia abnormalities are common in cancers like prostate cancer (PCa).
• The molecular basis for repressed primary ciliogenesis in PCa remains largely unknown.
• Transforming acidic coiled-coil protein-3 (TACC3) is a centrosomal protein involved in cell division and cancer pathogenesis.

Purpose of the Study:

• To investigate the role of TACC3 in primary ciliogenesis during prostate cancer progression.
• To elucidate the molecular mechanisms by which TACC3 affects primary cilia formation in PCa cells.

Main Methods:

• Quantitative analysis of TACC3 expression in PCa tissues.
• In vitro and in vivo experiments involving TACC3 knockdown in PCa cells.
• Co-immunoprecipitation assays to study protein interactions.

Main Results:

• TACC3 expression is significantly upregulated in PCa.
• Knockdown of TACC3 inhibits PCa cell proliferation and tumor growth.
• TACC3 interacts with filamin A and disrupts its association with meckelin, leading to impaired primary cilia formation.

Conclusions:

• TACC3 plays a critical role in suppressing primary ciliogenesis in prostate cancer.
• Targeting TACC3 may represent a novel therapeutic strategy for PCa by restoring cilia function and inhibiting tumor growth.